KELZNAMLONYVQP-SIDNZMCZSA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 6xotVvmh5d |
|---|---|
| InChI | InChI=1S/C28H22N4O2/c33-27-25-23-19-10-4-5-11-20(19)24(22-13-7-6-12-21(22)23)26(25)28(34)32(27)16-18-15-31(30-29-18)14-17-8-2-1-3-9-17/h1-13,15,23-26H,14,16H2/t23-,24+,25-,26?/m1/s1 |
| InChIKey | KELZNAMLONYVQP-SIDNZMCZSA-N |
| Mol Weight | 446.51 g/mol |
| Molecular Formula | C28H22N4O2 |
| Exact Mass | 446.174276 g/mol |
| Enantiomer InChIKey | KELZNAMLONYVQP-XMBLLSNASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
ADBRQHWXUHUCKS-KSNGJFOMSA-N
Dibenzo[5,6:7,8]bicyclo[2.2.2]octadiene-2,3-dicarboximide, N-(3,4-dimethoxybenzyl)-
2-(Oxo-2-(4-phenylpiperazin-1-yl)-ethyl)-3a,4,9,9atetrahydro-4,9-[1,2]benzeno-1H-benzo[f]isoindole-1,3(2H)-dione
N-((12,14-dioxo-11,12,14,15-tetrahydro-9H-9,10-[3,4]epipyrroloanthracen-13(10H)-yl)methyl)-N-(4-methoxyphenyl)acetamide
13-(3-hydroxyphenyl)-10,11-dihydro-9H-9,10-[3,4]epipyrroloanthracene-12,14(13H,15H)-dione
13-(3-aminophenyl)-10,11-dihydro-9H-9,10-[3,4]epipyrroloanthracene-12,14(13H,15H)-dione
17-(4-amino-3,5-dichlorophenyl)-17-azapentacyclo[6.6.5.0²,⁷.0⁹,¹⁴.0¹⁵,¹⁹]nonadeca-2(7),3,5,9(14),10,12-hexaene-16,18-dione
(9R,10S,11R,15S)-13-(thiazol-2-yl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione
13-(4-chloropyridin-2-yl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione
Anthracene, 9,10-dihydro-9,10-[1-(2-fluorophenyl)-2,5-dioxo-pyrrolidin-3,4-diyl]-
| Title | Journal or Book | Year |
|---|---|---|
| Triazolium Salts as Appropriate Catalytic Scaffolds for 1,4-Additions to α,β-Unsaturated Carbonyls | European Journal of Organic Chemistry | 2014 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.